Screener
Beta Bionics BBNX Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:DeferredRevenueNoncurrent.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Deferred revenue | 1,881 | 1,557 |
| Total current liabilities | 26,017 | 30,924 |
| Operating lease liabilities, net of current portion | 4,921 | 5,365 |
| Deferred revenue, net of current portion | 3,454 | 3,297 |
| Other long-term liabilities | 1,629 | 1,547 |
| Total liabilities | 36,021 | 41,133 |
| Commitments and contingencies (Note 15) | ||
| Stockholders’ equity: |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's deferred revenue?
- Beta Bionics (BBNX) reported deferred revenue of $3.45M in Q2 2026.
- How has Beta Bionics's deferred revenue changed year-over-year?
- Beta Bionics's deferred revenue increased by 29.4% year-over-year, from $2.67M to $3.45M.
- What is the long-term trend for Beta Bionics's deferred revenue?
- Over 2 years (2023 to 2025), Beta Bionics's deferred revenue has grown at a 259.6% compound annual growth rate (CAGR), from $255K to $3.3M.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about Beta Bionics's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude